期刊文献+

强直性脊柱炎患者肿瘤坏死因子α启动子308位点基因多态性分析 被引量:2

Gene polymorphism of the promoter region 308 site of the tumor necrosis factor α in ankylosing spondylitis
下载PDF
导出
摘要 目的:探讨肿瘤坏死因子(TNF)α启动子308位点基因多态性与强直性脊柱炎(AS)的相关性。方法:用聚合酶链反应—限制性片段长度多态性(PCR-RFLP)方法对112例AS患者和96例健康对照人群,以及98例HLA B27阳性AS患者和14例阴性AS患者的TNF-α启动子308位点基因多态性进行分析。结果:AS患者GG、GA和AA三种基因型频率分别为60.71%、36.61%和2.68%,G和A的等位基因频率分别为0.790和0.210,对照组三种基因型频率分别为81.25%、17.71%和1.04%,等位基因频率分别为0.901和0.099,两组基因型和等位基因频率分布有显著性差异(P<0.01),AS患者的A等位基因频率明显高于对照组。HLA-B27阳性AS患者和阴性AS患者的基因型频率亦有显著性差异(P<0.01)。结论:TNF-α启动子308位点基因多态性与AS相关,A等位基因可能增加AS的易感性。 Objective:To investigate the relationship between tumor necrosis factor α(TNF-α) gene polymorphism of the promoter region 308 site and ankylosing spondylitis (AS). Methods:Genomic DNA from 112 AS patients and 96 healthy controis, 98 HLA-B27 positive AS patients and 14 HLA-B27 negative AS patients were genotyped for TNF-α gene 308 site polymorphism by polymerase chain reaction restriction fragment length polymorphisms (PCR-RFLP). Results: Three genotypes (GG,GA and AA) frequencies in AS patients were 60.71%, 36.61% and 2.68%, and in controls were 81.25% , 17.71% and 1.04%, respectively. The allele frequencies (G and A) in AS patients were 0.790 and 0.210, and in controls were 0.901 and 0. 099, respectively. Allele A frequency in AS patients was significantly increased compared with the controls. Significant difference was also found in the distribution of genotypes between HLA-B27 positive AS patients and HLA-B27 negative AS patients. Conclusion: The gene polymorphism of the promoter region 308 sit of TNF-α is associated with AS, and allele A may play a role in AS susceptibility.
出处 《军医进修学院学报》 CAS 北大核心 2007年第4期279-281,共3页 Academic Journal of Pla Postgraduate Medical School
关键词 脊柱炎 强直性 肿瘤坏死因子Α 多态性 单核苷酸 spondylitis, ankylosing tumor necrosis factor-alpha polymorphism, single nucleotide
  • 相关文献

参考文献8

二级参考文献22

  • 1[1]Brewerton DA,Caferry M,Hart FD,et al.Ankylosing spondylitis and HLA-B27[J].Lancet,1973,1(7809):904-907.
  • 2[2]Braun J,van der Heijde D.Novel approaches in the treatment of ankylosing spondylitis and other spondyloarthritides[J].Expert Opin Investig Drugs,2003,12(7):1097-1109.
  • 3[3]van der Linden S,Valkenburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis.A proposal for modification of the New York criteria[J].Arthritis Rheum,1984,27(4):361-368.
  • 4[4]Braun J,Bollow M,Neure L,et al.Use of immunohistologic and in situ hybridization techniques in the examination of sacroiliac joint biopsy specimens from patients with ankylosing spondylitis[J].Arthritis Rheum,1995,38(4):499-505.
  • 5[6]González S,Torre-Alonso JC,Martínez-Borra J,et al.TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients[J].J Rheumatol,2001,28(6):1288-1293.
  • 6[7]Milicic A,Lindheimer F,Laval S,et al.Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondilitis[J].Genes Immun,2000,1(7):418-422.
  • 7[10]Vinasco J,Beraún Y,Nieto A,et al.Polymorphism at the TNF loci in rheumatoid arthritis[J].Tissue Antigens,1997,49(1):74-78.
  • 8Campbell RD,Trowsdale J.Map of the human MHC.Immunol Today,1993,14:349-352.
  • 9Pociot F,Briant L,Jongeneel CV,et al.Association of tumor necrosis factor (TNF) and class Ⅱ major histocompatibility complex alleles with the secretion of TNF-a and TNF-b by human mononuclear cells:a possible link to insulin-dependent diabetes mellitus.Eur J Immunol,1993,23:224-231.
  • 10Walston J,Seibert M,Yen CJ,et al.Tumor necrosis factor-α-238 and-308 polymorphisms do not associate with traits related to obesity and insulin resistance.Diabetes,1999,48:2096-2098.

共引文献105

同被引文献54

  • 1刘巧红,吴清敏,滕云,沈凌汛,王慧,陈燕,杨真荣.强直性脊柱炎与肿瘤坏死因子基因启动子-308位点多态性相关的假设验证(英文)[J].中国临床康复,2004,8(27):5974-5976. 被引量:4
  • 2韩星海,陈蕊雯,段世伟,杨波,蔡青,林懿,孙树汉.肿瘤坏死因子α基因多态性对强直性脊柱炎发病易感性和临床病变程度的影响(英文)[J].中国临床康复,2005,9(22):252-254. 被引量:3
  • 3杨清锐,张源潮,孙红胜,牟坤.强直性脊柱炎与肿瘤坏死因子-α基因启动子-308位点多态性关联研究的Meta分析[J].中华风湿病学杂志,2007,11(6):365-369. 被引量:1
  • 4Van der Linden S,Valkenburg HA,Cats A.Evaluation of diagnostic criteria for ankylosing spondylitis:a proposal for modification of the New York criteria[J].Arthritis Rheum,1984,27:361-368.
  • 5Tong Q,Zhao DB,Bajracharya P,et al.TNF-α-857 and-1031 polymorphisms predict good therapeutic response to TNF-α blockers in Chinese Han patients with ankylosing spondylitis[J].Pharmacogenomics,2012,13:1459-1467.
  • 6Verjans GM,Brinkman BM,van Doomik CE,et al.Polymor phism of tumour necrosis factor-alpha (TNF-alpha) at position308 in relation to ankylosing spondylitis[J].Clin Exp Immunol,1994,97:45-47.
  • 7Fraile A,Nieto A,Beraún Y,et al.Tumor necrosis factor gene polymorphisms in ankylosing spondylitis[J].Tissue Antigens,1998,51(4 Pt 1):386-390.
  • 8McGarry F,Walker R,Sturrock R,et al.The-308.1 polymorphism in the promoter region of the tumor necrosis factor gene is associated with ankylosing spondylitis independent of HLA-B27[J].J Rheumatol,1999,26:1110-1116.
  • 9Milicic A,Lindheimer F,Laval S,et al.Interethnic studies of TNF polymorphisms confirm the likely presence of a second MHC susceptibility locus in ankylosing spondylitis[J].Genes I mmun,2000,1:418-422.
  • 10González S,Torre-Alonso JC,Martínez-Borra J,et al.TNF-238A promoter polymorphism contributes to susceptibility to ankylosing spondylitis in HLA-B27 negative patients[J].J Rheumatol,2001,28:1288-1293.

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部